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Introduction
The Janani Suraksha Yojana (JSY) was launched in 2005 as
a response to high maternal mortality in India. The
scheme was driven by global evidence that conditional
cash transfers enable behaviour change, in this case, rise in
institutional delivery. The scheme had a differential incen-
tive entitlement based on urban or rural areas and high or
low performing states. The incentives for women in rural
areas of low performing states are: INR 1400 for institu-
tional delivery and INR 500 for home deliveries. However
in case of home deliveries many exclusionary practices
denied benefits of the scheme to women below 19 years of
age, higher parity and those entitled but without holding
the Below Poverty Line (BPL) card.
The paper draws on a study evaluating the effectiveness
of the scheme. The objectives of the evaluation were: to
assess trends in institutional delivery, the availability and
quality of care at delivery and in post natal period; the cap-
ability of health institutions and the role of village level
health workers called the Accredited Social Health Acti-
vists (ASHA). Impact evaluation on maternal mortality
was not attempted.
Methods
Three districts in each of eight EAG (Empowered Action
Group) states were selected as high performing, poor per-
forming and tribal districts. This categorisation was based
on number of institutional deliveries during 2008-09 and
proportion of scheduled caste/ tribe population. Quantita-
tive and qualitative methods were used to map the con-
texts, mechanisms and outcomes as evidenced from
primary and secondary data. The quantitative survey con-
ducted in twelve districts included 2759 institutional deliv-
eries and 710 home deliveries. In addition to assessing
access and quality of services, the evaluation aimed to cap-
ture what actually happened and why.
Results and discussion
The study shows that over 50% of women who had their
previous delivery at home had opted for institutional
delivery. However despite this increase, there were
about 40% home deliveries, with a range from 7.7% to
63%. Reasons reported for home delivery included lim-
ited access to transport, poor service quality, high costs
in institutions and cultural preferences.
Home deliveries were primarily occurring among
women who were younger than 19 years, had higher par-
ity, belonged to marginalized groups and without the
entitlement card that would provide preferential access.
The study also demonstrated significant out of pocket
expenses. Such expenses amounted to INR 1400 to INR
1600 on an average, primarily on account of payment for
transport and drugs. The steep increase in institutional
delivery, despite the fact that out of pocket expenditure
exceeded the cash transfer, signified that women pre-
ferred institutional delivery for health and safety reasons.
The increased availability of services was also a major
contributor to the change. Private sector accounted for
only about 12.5% of all deliveries. However, for complica-
tions, private sector provided 60% of care though for
complications that required hospitalization, the distribu-
tion between public and private sector was almost equal.
The study supports the contention that JSY has
resulted in an increase in institutional deliveries, and that
it has enabled and empowered poor women to access
public health facilities. However issues like the exclusion-
ary criteria for both home deliveries limit access of the
most vulnerable category. Persistent high out of pocket
payments also need to be addressed urgently. Increases
in human resources and infrastructure had not been suf-
ficient to provide quality services. Major recommenda-
tions emphasized, removal of all exclusionary criteria in
case of home and institutional deliveries, provision of
free pregnancy and newborn care and increasing infra-
structure and human resource providing emergency
obstetrics and neonatal care services.
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The interpretation of findings and recommendations in
the emerging context of universal health care, resulted in
converting a scheme based on the logic of conditional
cash transfer into an “enabling entitlement” approach.
Emphasis shifted to assured free drugs and transport to
pregnant, post partum women and newborns and the
pressure builds up to remove all conditionalities.
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